Hypercapnia as a preventative therapeutic strategy: Unveiling the neuroprotective potential and mechanisms

• Explores induced therapeutic hypercapnia as a potential neuroprotective strategy. • Focuses on preventing delayed cerebral ischemia after subarachnoid hemorrhage (SAH). • Analyzes existing research on mechanisms, benefits, and limitations of hypercapnia. • Highlights potential benefits, including enhanced cerebral blood flow, reduced neuronal apoptosis, and improved ischemic tolerance. • Discusses findings from animal models and clinical trials on controlled hypercapnia's role in mitigating secondary brain injuries. Hypercapnia, an increase in carbon dioxide (CO2) in the bloodstream, has been historically considered purely a pathological condition. However, based on several publications evaluating the adverse outcome of certain conditions with an additional hypercapnia, It was discovered that hypercapnia can be also utilized as a therapeutic strategy. The most common of these strategies is permissive hypercapnia, which is described by inducing PaCO2 in inhalation while breathing under a mechanical ventilator in order to reduce secondary lung injuries. Subsequently, hypercapnia was also discovered as an effective anti-apoptotic and anti-ischemic agent while evaluated on neurons in vitro and rat models. As a result, hypercapnia has been utilized as an intervention in several clinical trials regarding different neurological conditions, most notably Sub-Arachnoid Hemorrhage. Mild levels of induced Hypercapnia is capable of preventing serious delayed vasospastic ischemic attacks and increases the overall cerebral blood flow which leads to significantly better outcomes in patients with severe acute neurological conditions. The anti-apoptotic and neuroprotective characteristics of CO2 suggest induced hypercapnia as a potential strategy for preventing more chronic neuropathological conditions. This article aims to review the publications surrounding the neuro-therapeutic effects of hypercapnia and discuss the advantages, drawbacks, and future of hypercapnia as an impactful strategy in preventing and treating neurological pathologies.

Authors

Institutions

Publication Details

Journal
Brain Disorders
Published
2025-04-08
DOI
https://doi.org/10.1016/j.dscb.2025.100219
Citations
2
Primary Topic
Neonatal and fetal brain pathology
Type
article
Field-Weighted Citation Impact
6.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypercapnia as a preventative therapeutic strategy: Unveiling the neuroprotective potential and mechanisms

Mona Farhadi, Kiana Fazeli, Seyed Behnamedin Jameie
2 citations
Brain Disorders
Neonatal and fetal brain pathology
6.99
article

Hypercapnia as a preventative therapeutic strategy: Unveiling the neuroprotective potential and mechanisms

Mona Farhadi, Kiana Fazeli, Seyed Behnamedin Jameie
article en
2 citations

Abstract

• Explores induced therapeutic hypercapnia as a potential neuroprotective strategy. • Focuses on preventing delayed cerebral ischemia after subarachnoid hemorrhage (SAH). • Analyzes existing research on mechanisms, benefits, and limitations of hypercapnia. • Highlights potential benefits, including enhanced cerebral blood flow, reduced neuronal apoptosis, and improved ischemic tolerance. • Discusses findings from animal models and clinical trials on controlled hypercapnia's role in mitigating secondary brain injuries. Hypercapnia, an increase in carbon dioxide (CO2) in the bloodstream, has been historically considered purely a pathological condition. However, based on several publications evaluating the adverse outcome of certain conditions with an additional hypercapnia, It was discovered that hypercapnia can be also utilized as a therapeutic strategy. The most common of these strategies is permissive hypercapnia, which is described by inducing PaCO2 in inhalation while breathing under a mechanical ventilator in order to reduce secondary lung injuries. Subsequently, hypercapnia was also discovered as an effective anti-apoptotic and anti-ischemic agent while evaluated on neurons in vitro and rat models. As a result, hypercapnia has been utilized as an intervention in several clinical trials regarding different neurological conditions, most notably Sub-Arachnoid Hemorrhage. Mild levels of induced Hypercapnia is capable of preventing serious delayed vasospastic ischemic attacks and increases the overall cerebral blood flow which leads to significantly better outcomes in patients with severe acute neurological conditions. The anti-apoptotic and neuroprotective characteristics of CO2 suggest induced hypercapnia as a potential strategy for preventing more chronic neuropathological conditions. This article aims to review the publications surrounding the neuro-therapeutic effects of hypercapnia and discuss the advantages, drawbacks, and future of hypercapnia as an impactful strategy in preventing and treating neurological pathologies.

Brain DisordersVol. 18
Iran University of Medical Sciences (IR), Islamic Azad University, Karaj (IR)
Iran University of Medical Sciences, Kerman Neuroscience Research Center, Kerman University of Medical Sciences
Openalex Percentile: Top 5%
Neonatal and fetal brain pathology
6.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.